...
首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Adding decision models to systematic reviews: Informing a framework for deciding when and how to do so
【24h】

Adding decision models to systematic reviews: Informing a framework for deciding when and how to do so

机译:在系统评价中添加决策模型:为确定何时以及如何进行决策提供框架

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: Decision models are sometimes used alongside systematic reviews to synthesize evidence. Clarity, however, is lacking about when and how to conduct modeling studies in tandem with systematic reviews, as well as about how to evaluate and present model results. The objective of this study was to collect and analyze information from various sources to inform the development of a framework for deciding when and how a decision model should be added to a systematic review. Methods: We collected data through 1) review and analysis of evidence reports that used decision models; 2) review and synthesis of current best practices for the development of decision models; 3) interviews of Evidence-Based Practice Center directors and selected staff, United States Preventive Services Task Force members, and decision modelers who developed models used by the United States Preventive Services Task Force; and 4) a focus group of expert modelers. Results: Models are well suited to address gaps in the literature, better suited for certain types of research questions, and essential for determining the value of information relating to future research. Opinions differ regarding whether model outputs constitute evidence, but interviewees expressed concern over the lack of standards and directions in grading and reporting such evidence. Interviews of stakeholders and modelers revealed the importance of communication and presentation of model results as well as the importance of model literacy and involvement of stakeholders. Conclusions: The study demonstrates the need for a framework for deciding when and how to use models alongside systematic reviews and provides information to develop such a framework. ? 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
机译:目标:决策模型有时会与系统评价一起使用,以综合证据。但是,缺乏关于何时以及如何与系统评价一起进行建模研究以及如何评估和展示模型结果的清晰性。这项研究的目的是收集和分析来自各种来源的信息,以为框架的发展提供信息,该框架用于决定何时以及如何将决策模型添加到系统评价中。方法:我们通过以下方法收集数据:1)审查和分析使用决策模型的证据报告; 2)审查和综合用于决策模型开发的当前最佳实践; 3)对循证实践中心主任和选定人员,美国预防服务工作队成员以及开发了美国预防服务工作队使用的模型的决策建模者的采访;和4)专家建模师焦点小组。结果:模型非常适合解决文献中的空白,更适合于某些类型的研究问题,并且对于确定与未来研究有关的信息的价值至关重要。关于模型输出是否构成证据,意见不一,但受访者对在分级和报告此类证据时缺乏标准和方向表示担忧。利益相关者和建模者的访谈显示了交流和展示模型结果的重要性,以及模型素养和利益相关者参与的重要性。结论:研究表明需要一个框架来决定何时以及如何使用模型以及系统评价,并提供信息以开发这样的框架。 ? 2013年国际药物经济学和结果研究学会(ISPOR)。由Elsevier Inc.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号